Pharmacology/Therapy News http://www.mdlinx.com/HemeOncLinx/news.cfm/newspage/1/spec_id/17/subspec_id/398 Pharmacology/Therapy en-us Copyright 2009 MDLinx, Inc. <![CDATA[Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: Consortium for improving survival of lymphoma study ]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940859 11/9/2009 Journal of Clinical Oncology]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940859 <![CDATA[A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2935341 11/9/2009 Cancer]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2935341 <![CDATA[Continuous 5-fluorouracil infusion plus long acting Octreotide in advanced well differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network.]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2939475 11/9/2009 BMC Cancer]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2939475 <![CDATA[Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia ]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940861 11/9/2009 Journal of Clinical Oncology]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940861 <![CDATA[Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: A Southwest Oncology Group Study]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2933570 11/9/2009 Annals of Oncology]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2933570 <![CDATA[Phase II Study of Preoperative Gefitinib in Clinical Stage I Non-Small-Cell Lung Cancer]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940871 11/9/2009 Journal of Clinical Oncology]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940871 <![CDATA[Effect of Epoetin Alfa on Survival and Cancer Treatment-Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940870 11/9/2009 Journal of Clinical Oncology]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940870 <![CDATA[Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2939501 11/9/2009 Clinical Cancer Research]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2939501 <![CDATA[Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940843 11/9/2009 Journal of Clinical Oncology]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940843 <![CDATA[Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2939983 11/9/2009 American Journal of Hematology]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2939983